Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.8%

5 terminated/withdrawn out of 593 trials

Success Rate

96.6%

+10.1% vs industry average

Late-Stage Pipeline

16%

96 trials in Phase 3/4

Results Transparency

1%

2 of 140 completed trials have results

Key Signals

194 recruiting2 with results4 withdrawn

Enrollment Performance

Analytics

N/A
234(55.3%)
Phase 3
50(11.8%)
Phase 4
46(10.9%)
Phase 2
43(10.2%)
Phase 1
27(6.4%)
Early Phase 1
23(5.4%)
423Total
N/A(234)
Phase 3(50)
Phase 4(46)
Phase 2(43)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (593)

Showing 20 of 593 trials
NCT07242599Phase 3Not Yet Recruiting

Ongericimab Injection Reducing Recurrence of Ischemic Stroke

Role: lead

NCT06064734Not ApplicableCompleted

Low-Frequency REpetitive TRanscranial Magnetic Stimulation in ACute Ischemic StrokE Within 48 Hours

Role: lead

NCT07532122Completed

Postoperative Anxiety and Depression Among Chinese Elderly Patients

Role: collaborator

NCT07526987Phase 3Not Yet Recruiting

Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis

Role: lead

NCT07370246Not ApplicableRecruiting

CAS for Stenosis With High-risk Features for CEA

Role: lead

NCT07527013Phase 3Not Yet Recruiting

Stratified Blood Pressure Management Strategy After Endovascular Treatment for Acute Ischemic Stroke

Role: lead

NCT07520370Not ApplicableNot Yet Recruiting

Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor

Role: lead

NCT06064747Not ApplicableCompleted

Low-Frequency REpetitive TRanscranial Magnetic Stimulation Combined With Endovascular Treatment in ACute Ischemic StrokE

Role: lead

NCT06400407Phase 2Completed

Lesion Network MApping Navigated Continuous Theta-burst STimulation for Motor REcovery in Acute Ischemic Stroke

Role: lead

NCT07517354Recruiting

Family-Based Moyamoya Susceptibility and Early Detection

Role: lead

NCT07341854Not ApplicableNot Yet Recruiting

Dexamethasone Palmitate for Postoperative Pain

Role: lead

NCT06954155Phase 3Recruiting

Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND

Role: lead

NCT07047014Phase 3Recruiting

Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke

Role: lead

NCT07361796Not ApplicableRecruiting

The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster

Role: lead

NCT07471256Phase 3Not Yet Recruiting

Neuronavigation-assisted Stereotactic Minimally Invasive Puncture With Tenecteplase for Acute Lobar Intracerebral Hemorrhage

Role: lead

NCT06482905Phase 1Recruiting

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

Role: collaborator

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT06681948Not ApplicableCompleted

The Ketogenic Diet in the Treatment of Alzheimer's Disease

Role: collaborator

NCT07307170Not ApplicableRecruiting

The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster

Role: lead